期刊文献+

卡马西平致Stevens-Johnson综合征和中毒性表皮坏死松解症24例临床特点及治疗分析 被引量:3

A clinical and treatment analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis induced by carbamazepine in 24 patients
下载PDF
导出
摘要 目的探讨卡马西平所致Stevens-Johnson综合征(Stevens-Johnson syndrome,SJS)和中毒性表皮坏死松解症(toxic epidermal necrolysis,TEN)的临床特点及治疗转归。方法对无锡市第二人民医院皮肤科2009年—2018年住院治疗的卡马西平所致的24例SJS/TEN重症药疹临床数据进行回顾性分析。结果24例患者中SJS患者20例,TEN患者4例。潜伏期平均(25.0±15.3)d。发热、白细胞数目异常、黏膜损伤、肝功能损伤为常见的临床症状、体征及实验室检查。24例患者均早期足量给予糖皮质激素和(或)人血丙种球蛋白治疗,1例因败血症转入内科治疗,其余23例均好转出院。结论卡马西平所致SJS/TEN重症药疹有潜伏期长、临床症状重、病程长的特点,早期足量给予糖皮质激素和(或)人血丙种球蛋白治疗是临床治愈的关键。 Objective To study the clinical features and the treatment of Stevens-Johnson syndrome(SJS)and toxic epidermal necrolysis(TEN)induced by carbamazepine.Methods Twenty-four patients with SJS/TEN induced by carbamazepine in Dermatology Department of Wuxi No.2 People’s Hospital from 2009 to 2018 were included in the study.Results There were twenty SJS patients and four TEN patients in the 24 cases.The average incubation period was 25.0±15.3 days.Fever,abnormal leukocytes count,mucocutaneous lesions,liver injury were the most common systemic symptoms.All the 24 patients had been given enough systemic steroids and/or intravenous immunoglobulin in the early stage of the disease.One case was transferred to internal medicine department because of hematosepsis,the other 23 cases were cured.Conclusion SJS/TEN induced by carbamazepine is characterized by the longer incubation period,serious symptoms and longer disease duration.Early adequate administration of glucocorticoids and/or human gamma globulin is the key to clinical cure.
作者 夏汝山 孙慧 蒋屏东 赖美玲 张晓利 XIA Ru-shan;SUN Hui;JIANG Ping-dong(Department of Dermatology,Wuxi No.2 People’s Hospital,Wuxi 214000,China)
出处 《实用皮肤病学杂志》 2019年第6期337-339,共3页 Journal of Practical Dermatology
关键词 卡马西平 STEVENS-JOHNSON综合征 中毒性表皮坏死松解症 临床分析 Carbamazepine SJS TEN Clinical analysis
  • 相关文献

参考文献5

二级参考文献23

  • 1孙端元.药理学[M].北京:人民军医出版社,2000:83.
  • 2Faigle JW, Menge GP. Pharmacokinetics and metabolic fea- tures of oxcarbazepine and their clinical significance: compari- son with carbamzepine[J]. Int Clin Psychopharmacol, 1990,5 : 73-82.
  • 3Loryd P, Flescb G, Dietetic W, et al. Clinical pharmacology and pharmacokinetics of oxcarbazepine[J ]. Epilepsia, 1994,35 (Suppl 3) :S10-S13.
  • 4Sheiner LB,Rosenberg B, Marathe W. Estimation of popula- tion characteristics of pharmacokinetic parameters from routine clinical date[J]. J Pharmacokinet Biopharm, 1997,5 (5) : 445- 479.
  • 5Sheiner LB. The population approach to pharmacokinetinetic date analysis; rationale and standard date analysis methods[J]. Drug Metab Rev, 1984,25 : 153-171.
  • 6Beal SL. Population pharmacokinetic date and parameter esti- mation based on their first two statistical moments[J]. Drug Metab Rev, 1984,15 (1-2) : 173-193.
  • 7Sheiner LB. An introduction to mixed effect model: concepts, definitions,and justification[-J]. J Pharm Biopharm, 1991,19 (3) : 113.
  • 8WadeJR,Kelman AW, Hwoie CA,et al. Effect of misspecifica- tion of the absorption process on subsequent parameter esti- mation in population analysis[J]. J Pharmacokinetic Biophar- maceutics, 1993, 21 (2) :209- 222.
  • 9Cramer JA, Prrrine K, Devinsky O, et al. Development and erosseultural translations of a 31-item quality of life in epilepsy inventory [J]. Epilepsia, 1998,39 ( 1 ) : 81-88.
  • 10van der Kuy PH,Koppejan EH,Wirtz JJ. Rectal absorption of oxearbazepine[J]. Pharm World Sci,2000,22(4):165-166.

共引文献41

同被引文献23

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部